Deferasirox Tablet, For Suspension
Product Images NDC 62756-570

5 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 62756-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-deferasirox-chemical-structure (Spl Deferasirox Chemical Structure)

Spl-deferasirox-chemical-structure (Spl Deferasirox Chemical Structure)
Chemical structure of deferasirox, depicting its molecular framework including aromatic rings, hydroxyl groups, and nitrogen atoms in a triazole ring.*
FDA Label Image

Spl-deferasirox-figure-1 (Spl Deferasirox Figure 1)

Spl-deferasirox-figure-1 (Spl Deferasirox Figure 1)
A bar chart showing the change in liver iron content and serum ferritin levels at different doses of deferasirox tablets (5, 10, 20, and 30 mg/kg/day). Liver iron content is shown with open bars, serum ferritin with solid bars, with dose on the x-axis and changes measured on two y-axes: mg Fe/g dry weight for liver iron content and mcg/L for serum ferritin.*
FDA Label Image

Spl-deferasirox-label-125mg 1 (Spl Deferasirox Label 125mg 1)

Spl-deferasirox-label-125mg 1 (Spl Deferasirox Label 125mg 1)
Label for deferasirox Tablets for Oral Suspension, 125 mg strength, oral tablet for suspension dosage form, containing 30 tablets per bottle. The label includes directions not to chew or swallow whole, storage instructions at controlled room temperature, and manufacturer information for Sun Pharmaceutical Industries, Inc. The label also features a barcode and space for lot and expiration date details.*
FDA Label Image

Spl-deferasirox-label-250mg 2 (Spl Deferasirox Label 250mg 2)

Spl-deferasirox-label-250mg 2 (Spl Deferasirox Label 250mg 2)
Label for Deferasirox Tablets for Oral Suspension, 250 mg strength. The label includes dosage form, strength, and administration instructions not to chew or swallow whole. It lists storage conditions and manufacturer Sun Pharmaceutical Industries Ltd., with distribution by Sun Pharmaceutical Industries, Inc. The package contains 30 tablets. Barcodes and lot/expiration date placeholders are visible.*
FDA Label Image

Spl-deferasirox-label-500mg 3 (Spl Deferasirox Label 500mg 3)

Spl-deferasirox-label-500mg 3 (Spl Deferasirox Label 500mg 3)
Label for deferasirox 500 mg tablets for oral suspension from Sun Pharmaceutical Industries, Inc. The label states storage instructions, dosage form, and warnings including to not chew or swallow whole and the need to disperse tablets in water, orange, or apple juice before ingestion. The package contains 30 tablets, and it includes distribution and manufacturing details with a barcode and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.